Sorbie Bornholm Completes Two Canadian Securities Exchange Private Placements Totalling CAD $8 Million

Sorbie Bornholm L.P. and Sorbie Investments LLP (together "Sorbie") has completed two concurrent private placements totalling approximately CAD$8 million into Canadian Securities Exchange-listed companies. Sorbie subscribed for units in Defence Therapeutics Inc. ("Defence") and Replenish Nutrients Holding Corp. ("Replenish"), each consisting of one common share and one warrant exercisable for a two-year period.

Both transactions were structured using Sorbie's Sharing Agreement, under which subscription proceeds are delivered as UK Government Bonds held under ISDA Credit Support Annexes and released monthly as the transactions settle.

Orrick represented Sorbie in the transactions.

THE COMPANY

Sorbie is a global investment firm providing strategic, longer-term capital to listed micro, small and mid-cap growth companies through its proprietary "Sharing Agreement" model, a differentiated investment structure designed to align investor and issuer interests. Under this model, capital is not delivered as a traditional lump-sum financing but is deployed over time, typically backed by high-quality assets such as UK Government Bonds held under ISDA sharing arrangements. This staged funding approach allows companies to access committed capital in line with operational needs, while providing Sorbie with structured downside protection.

THE IMPACT

Defence (CSE: DTC, OTCQB: DTCFF, FSE: DTC) is a Canadian biotechnology and precision intracellular drug-delivery company headquartered in Montreal, Québec. The company's proprietary Accum® platform enables precision delivery of vaccine antigens and antibody-drug conjugates ("ADCs") in their intact form to target cells, with the goal of increasing efficacy and potency against cancer and infectious diseases.

Replenish Nutrients (CSE: ERTH, OTC: VVIVF) is a Canadian agriculture biotechnology company headquartered in Okotoks, Alberta. The company manufactures and sells proprietary regenerative fertilizer products containing essential macro and micronutrients and biological material, using a proprietary zero-waste manufacturing process.

The transactions provide both companies with committed growth capital, with additional funding potential through warrants. Defence will use the proceeds to advance its ADC and radiopharmaceutical programs and support working capital, while Replenish will scale production and expand licensing partnerships. Sorbie's Sharing Agreement structure delivers capital over time, backed by UK Government Bonds under ISDA arrangements.

THE TEAM

The Orrick team was led by Ed Lukins, supported by Abigail Parkin.

LEARN MORE

• Read more Orrick client results